Biktarvy, formally known as bictegravir sulfate, represents a powerful single-tablet therapy for controlling HIV infection. This drug combines three essential antiviral agents: bictegravir, emtricitabine, and tenofovir alafenamide. It works by inhibiting the HIV's ability to copy within the body, significantly lowering the viral quantity. For man